Randomized Study Evaluating Ixabepilone Plus Capecitabine or Docetaxel Plus Capecitabine in Metastatic Breast Cancer
Public ClinicalTrials.gov record NCT00546364. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
IXTEND: A Randomized Phase 2 Study to Evaluate the Combination of Ixabepilone Plus Capecitabine or Capecitabine Plus Docetaxel in the Treatment of Metastatic Breast Cancer
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to assess the effect of ixabepilone plus capecitabine or docetaxel plus capecitabine on shrinking or slowing the growth of metastatic breast cancer in women. The safety of this combination therapy will also be evaluated.
Study identification
- NCT ID
- NCT00546364
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 62 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 31, 2008
- Primary completion
- Feb 28, 2010
- Completion
- Feb 28, 2010
- Last update posted
- Mar 9, 2016
2008 – 2010
United States locations
- U.S. sites
- 60
- U.S. states
- 29
- U.S. cities
- 55
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Dch Cancer Treatment Center | Tuscaloosa | Alabama | 35401 | — |
| Scripps Cancer Center | La Jolla | California | 92037 | — |
| Cancer Center of Central Connecticut | Southington | Connecticut | 06489 | — |
| Local Institution | Newark | Delaware | 19718 | — |
| Georgetown University Medical Center | Washington D.C. | District of Columbia | 20007 | — |
| Local Institution | Jacksonville | Florida | 32209 | — |
| Local Institution | Miami | Florida | 33176 | — |
| Medical Oncology Associates of Augusta, PC | Augusta | Georgia | 30901 | — |
| Local Institution | Honolulu | Hawaii | 96813 | — |
| Northwestern University Feinberg School of Medicine | Chicago | Illinois | 60611 | — |
| John W Kugler, MD | Peoria | Illinois | 61615 | — |
| Midwestern Regional Medical Center | Zion | Illinois | 60099 | — |
| Center for Cancer Care at Goshen Health System | Goshen | Indiana | 46526 | — |
| Monroe Medical Associates | Munster | Indiana | 46321 | — |
| Cancer Center of Kansas | Wichita | Kansas | 67214 | — |
| University of Kentucky | Lexington | Kentucky | 40536 | — |
| University Medical Center, Inc | Louisville | Kentucky | 40202 | — |
| Hematology/Oncology Clinic | Baton Rouge | Louisiana | 70809 | — |
| Mary Bird Perkins Cancer Center | Baton Rouge | Louisiana | 70809 | — |
| Sinai Hospital of Baltimore | Baltimore | Maryland | 21215 | — |
| Center for Cancer & Blood Disorders, PC | Bethesda | Maryland | 20817 | — |
| Jackson Oncology Associates, Pllc | Jackson | Mississippi | 39202 | — |
| The Center for Cancer and Hematologic Disease | Cherry Hill | New Jersey | 08003 | — |
| The Cancer Center at Hackensack University Medical Center | Hackensack | New Jersey | 07601 | — |
| Howell Office Plaza | Howell Township | New Jersey | 07731 | — |
| Local Institution | Newark | New Jersey | 07112 | — |
| Cooper Hospital, Division of Hematology/Oncology | Voorhees Township | New Jersey | 08043 | — |
| UNM Cancer Center | Albuquerque | New Mexico | 87106 | — |
| New Mexico Cancer Care Associates (NMCCA) | Santa Fe | New Mexico | 87505 | — |
| Arena Oncology Associates, PC | Lake Success | New York | 11042 | — |
| Hematology Oncology Associates of Rockland | Nyack | New York | 10960 | — |
| Gaston Hematology and Oncology | Gastonia | North Carolina | 28054 | — |
| Marion L Shepard Cancer Center | Washington | North Carolina | 27889 | — |
| Akron General Medical Center | Akron | Ohio | 44302 | — |
| Summa Health System | Akron | Ohio | 44304 | — |
| Local Institution | Canton | Ohio | 44710 | — |
| Mid Ohio Oncology/Hematology, Inc, dba The Mark H Zangmeister Center | Columbus | Ohio | 43219 | — |
| Doylestown Hospital | Doylestown | Pennsylvania | 18901 | — |
| Hematology & Oncology Associates of Nepa | Dunmore | Pennsylvania | 18512 | — |
| Regional Hematology Oncology, PC | Langhorne | Pennsylvania | 19047 | — |
| St Mary Medical Center | Langhorne | Pennsylvania | 19047 | — |
| Local Institution | Philadelphia | Pennsylvania | 19140 | — |
| Albert Einstein Cancer Center | Philadelphia | Pennsylvania | 19141 | — |
| Local Institution | Woonsocket | Rhode Island | 02895 | — |
| Charleston Cancer Center | Charleston | South Carolina | 29406 | — |
| Lowcountry Hematology & Oncology, PA | Mt. Pleasant | South Carolina | 29464 | — |
| Santee Hematology/Oncology | Sumter | South Carolina | 29150 | — |
| Sanford Cancer Center Oncology Clinic | Sioux Falls | South Dakota | 57104 | — |
| Kingsport Hematology Oncology | Kingsport | Tennessee | 37660 | — |
| The University of Tennessee Medical Center | Knoxville | Tennessee | 37920 | — |
| Austin Cancer Centers | Austin | Texas | 78759 | — |
| Cancer Specialists of South Texas | Corpus Christi | Texas | 78412 | — |
| Coastal Bend Cancer Center | Corpus Christi | Texas | 78463 | — |
| Edward L Middleman, MD | Duncanville | Texas | 75137 | — |
| Section Chief Medical Oncology | Houston | Texas | 77030 | — |
| Jose A Figueroa, MD | Lubbock | Texas | 79410 | — |
| Southlake Oncology | Southlake | Texas | 76092 | — |
| Peninsula Cancer Institute | Newport News | Virginia | 23601 | — |
| Providence Cancer Center | Spokane | Washington | 99204 | — |
| Leah L Dietrich, MD | La Crosse | Wisconsin | 54601 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00546364, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 9, 2016 · Synced Sep 2, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00546364 live on ClinicalTrials.gov.